Cargando…

Modified Banxia Xiexin Decoction Ameliorates Polycystic Ovarian Syndrome With Insulin Resistance by Regulating Intestinal Microbiota

OBJECTIVE: To analyze the characteristics of the intestinal microbiota of polycystic ovarian syndrome with insulin resistance (PCOS-IR) and explore the possible mechanism of modified Banxia Xiexin Decoction in the treatment of PCOS-IR. METHODS: A total of 17 specific pathogen-free (SPF) female Sprag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hongyu, Chen, Rufeng, Zheng, Dongxue, Xiong, Feng, Jia, Fan, Liu, Jinyuan, Zhang, Lili, Zhang, Nana, Zhu, Shiqin, Liu, Yongmei, Zhao, Linhua, Liu, Xinmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127304/ https://www.ncbi.nlm.nih.gov/pubmed/35619648 http://dx.doi.org/10.3389/fcimb.2022.854796

Ejemplares similares

Banxia Xiexin decoction: A review on phytochemical, pharmacological, clinical and pharmacokinetic investigations
por: Zhou, Zehua, et al.
Publicado: (2023)

Efficacy of Banxia Xiexin decoction for chronic atrophic gastritis: A systematic review and meta-analysis
por: Cao, Yang, et al.
Publicado: (2020)

Investigation of Molecular Mechanism of Banxia Xiexin Decoction in Colon Cancer via Network Pharmacology and In Vivo Studies
por: Ma, Lili, et al.
Publicado: (2022)

Effectiveness of Banxia Xiexin Decoction in the treatment of precancerous lesions: A protocol for systematic review and meta-analysis
por: Yi, Ying, et al.
Publicado: (2021)

Treatment of the Gastroesophageal Reflux Disease with Chinese Herbal Medicine (BanxiaXiexin Decoction): Evidence from Meta-Analysis
por: Liu, Jiali, et al.
Publicado: (2022)

Banxia Xiexin Decoction in the treatment of chronic atrophic gastritis: A protocol for systematic review and meta-analysis
por: Ji, Qing, et al.
Publicado: (2020)

Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module
por: Yu, Ying, et al.
Publicado: (2020)

Banxia Xiexin Decoction in the treatment of Hp-associated peptic ulcer: A protocol for systematic review and meta-analysis
por: Zhu, Weikai, et al.
Publicado: (2021)

Banxia Xiexin Decoction Ameliorates t-BHP-Induced Apoptosis in Pancreatic Beta Cells by Activating the PI3K/AKT/FOXO1 Signaling Pathway
por: Du, Li-juan, et al.
Publicado: (2020)

Efficacy and safety of Banxia Xiexin Decoction as a complementary treatment for gastric cancer: A protocol for systematic review and meta-analysis
por: Zhang, Meiqing, et al.
Publicado: (2021)

Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer
por: Lu, Hongyang, et al.
Publicado: (2018)

Efficacy and Safety of Modified Banxia Xiexin Decoction (Pinellia Decoction for Draining the Heart) for Gastroesophageal Reflux Disease in Adults: A Systematic Review and Meta-Analysis
por: Dai, Yunkai, et al.
Publicado: (2017)

Banxia Xiexin decoction ameliorated cognition via the regulation of insulin pathways and glucose transporters in the hippocampus of APPswe/PS1dE9 mice
por: Chen, Fang, et al.
Publicado: (2018)

Traditional Banxia Xiexin decoction inhibits invasion, metastasis, and epithelial mesenchymal transition in gastric cancer by reducing lncRNA TUC338 expression
por: Dai, Xiaojun, et al.
Publicado: (2023)

Efficacy and Safety of Banxia XieXin Decoction, a Blended Traditional Chinese Medicine, as Monotherapy for Patients With Advanced Hepatocellular Carcinoma
por: Wang, Lijuan, et al.
Publicado: (2020)

Mechanisms of Banxia Xiexin Decoction Underlying Chronic Atrophic Gastritis via Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations
por: Chang, Cheng, et al.
Publicado: (2022)

Banxia Xiexin Decoction Inhibits the Expression of PD-L1 Through Multi-Target and Multi-Pathway Regulation of Major Oncogenes in Gastric Cancer
por: Feng, Xuan, et al.
Publicado: (2021)

Herbal medicine, Banxia-xiexin tang, for functional dyspepsia: a systematic review and meta-analysis
por: Kim, Keumji, et al.
Publicado: (2023)

Efficacy of modified Banxia Xiexin decoction in the management of Wei-Pi syndrome (postprandial distress syndrome): study protocol for a randomized, waitlist-controlled trial
por: Sin, Sai Ho, et al.
Publicado: (2021)

Gualou Xiebai Banxia decoction ameliorates Poloxamer 407-induced hyperlipidemia
por: Luo, Mingzhu, et al.
Publicado: (2021)

Anti-Apoptotic Role of Sanhuang Xiexin Decoction and Anisodamine in Endotoxemia
por: Liu, Zixuan, et al.
Publicado: (2021)

Gancao Xiexin Decoction Ameliorates Ulcerative Colitis in Mice via Modulating Gut Microbiota and Metabolites
por: Luo, Yi-ting, et al.
Publicado: (2022)

Banxia Xiexin tang for gastro-oesophageal reflux disease: A protocol for a systematic review of controlled trials
por: Kang, Bohyung, et al.
Publicado: (2018)

Molecular targets and mechanisms involved in the action of Banxia Shumi decoction in insomnia treatment
por: Zhang, Yan, et al.
Publicado: (2023)

Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regulating MGMT expression via IL-6/JAK/STAT3-mediated PD-L1 activity
por: Feng, Xuan, et al.
Publicado: (2021)

Pi-Dan-Jian-Qing Decoction Ameliorates Type 2 Diabetes Mellitus Through Regulating the Gut Microbiota and Serum Metabolism
por: Xie, Xuehua, et al.
Publicado: (2021)

Sanhuang Xiexin decoction promotes good functional outcome in acute ischemic stroke
por: Song, Juexian, et al.
Publicado: (2018)

Banxia Baizhu Tianma decoction for hyperlipidemia: Protocol for a systematic review and meta-analysis
por: Cai, Hairong, et al.
Publicado: (2018)

Acute and subacute oral toxicity assessment of Gancao Xiexin decoction in Sprague-Dawley rats
por: Ru, Li, et al.
Publicado: (2023)

Identification of the significant pathways of Banxia Houpu decoction in the treatment of depression based on network pharmacology
por: Chen, Zi-ying, et al.
Publicado: (2020)

Gut Microbiota: The Potential Key Target of TCM’s Therapeutic Effect of Treating Different Diseases Using the Same Method—UC and T2DM as Examples
por: Zhang, Boxun, et al.
Publicado: (2022)

Exploration of Gancao Xiexin decoction for treatment of Behcet disease based on network pharmacology and molecular docking
por: Zhang, Xin
Publicado: (2022)

Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome
por: Li, Na, et al.
Publicado: (2021)

Banxia-Houpu decoction diminishes iron toxicity damage in heart induced by chronic intermittent hypoxia
por: Song, Ji-Xian, et al.
Publicado: (2022)

Baihu renshen decoction ameliorates type 2 diabetes mellitus in rats through affecting gut microbiota enhancing gut permeability and inhibiting TLR4/NF-κB-mediated inflammatory response
por: Yao, Bin, et al.
Publicado: (2022)

Banxia Baizhu Tianma Decoction for Essential Hypertension: A Systematic Review of Randomized Controlled Trials
por: Xiong, Xingjiang, et al.
Publicado: (2012)

Polycystic ovary syndrome and 25-hydroxyvitamin D: A bidirectional two-sample Mendelian randomization study
por: Zhang, Nana, et al.
Publicado: (2023)

Integrated microbiome and metabolome analysis reveals the potential therapeutic mechanism of Qing-Fei-Pai-Du decoction in mice with coronavirus-induced pneumonia
por: Wu, Gaosong, et al.
Publicado: (2022)

Herbal medicine (Gancao Xiexin decoction) for Behcet disease: A systematic review protocol
por: Wu, Dongjie, et al.
Publicado: (2018)

Comparison of the Gut Microbiota Between Pulsatilla Decoction and Levofloxacin Hydrochloride Therapy on Escherichia coli Infection
por: Liu, Xiaoye, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3738ecr71df2ppp1m7ds489blm